Gene · 6950
Papers1,592
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 1,592
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Histopathology of Skeletal Muscle in a Distal Motor Neuropathy Associated with a Mutant CCT5 Subunit: Clues for Future Developments to Improve Differential Diagnosis and Personalized Therapy. | Biology (Basel) | 2023 | 37237456 | PubTator, text mining | PubMed |
| TP53BP1, a dual-coding gene, uses promoter switching and translational reinitiation to express a smORF protein. | iScience | 2023 | 37216125 | PubTator, text mining | PubMed |
| Pathway and mechanism of tubulin folding mediated by TRiC/CCT along its ATPase cycle revealed using cryo-EM. | Commun Biol | 2023 | 37193829 | Swiss-Prot, curated | PubMed |
| Morphogenesis and functional organization of viral inclusion bodies. | Cell Insight | 2023 | 37193093 | PubTator, text mining | PubMed |
| Advances in deciphering the interactions between viral proteins of influenza A virus and host cellular proteins. | Cell Insight | 2023 | 37193064 | PubTator, text mining | PubMed |
| Elucidating cellular interactome of chikungunya virus identifies host dependency factors. | Virol Sin | 2023 | 37182691 | PubTator, text mining | PubMed |
| Protein Aggregates and Aggrephagy in Myopathies. | Int J Mol Sci | 2023 | 37176163 | PubTator, text mining | PubMed |
| Knockdown of ARHGAP30 inhibits ovarian cancer cell proliferation, migration, and invasiveness by suppressing the PI3K/AKT/mTOR signaling pathway. | Eur J Histochem | 2023 | 37170915 | PubTator, text mining | PubMed |
| The SALENTO prognostic model for limited-stage peripheral T-cell lymphoma from the International T-Cell Project Network. | Blood Adv | 2023 | 37163360 | PubTator, text mining | PubMed |
| Targeting HSF1 for cancer treatment: mechanisms and inhibitor development. | Theranostics | 2023 | 37153737 | PubTator, text mining | PubMed |
| Elucidating the toxic effect and disease mechanisms associated with Lyso-Gb3 in Fabry disease. | Hum Mol Genet | 2023 | 37145097 | PubTator, text mining | PubMed |
| Construction of a novel molecular typing and scoring system for anoikis distinguishes between different prognostic risks and treatment responsiveness in low-grade glioma. | Front Immunol | 2023 | 37114037 | PubTator, text mining | PubMed |
| Comparative Analysis of Molecular Functions and Biological Role of Proteins from Cell-Free DNA-Protein Complexes Circulating in Plasma of Healthy Females and Breast Cancer Patients. | Int J Mol Sci | 2023 | 37108441 | PubTator, text mining | PubMed |
| Tubulin Post-Translational Modifications: The Elusive Roles of Acetylation. | Biology (Basel) | 2023 | 37106761 | PubTator, text mining | PubMed |
| The association between white matter tract structural connectivity and information processing speed in relapsing-remitting multiple sclerosis. | Neurol Sci | 2023 | 37103603 | PubTator, text mining | PubMed |
| Role of CCT4/ErbB signaling in nephroblastoma: Implications for a biomarker of Wilms tumor. | Medicine (Baltimore) | 2023 | 37058032 | PubTator, text mining | PubMed |
| Global-feature of autoimmune glomerulonephritis using proteomic analysis of laser capture microdissected glomeruli. | Front Immunol | 2023 | 37033921 | PubTator, text mining | PubMed |
| Effects of prenatal pesticide exposure on the fetal brain and placenta transcriptomes in a rodent model. | Toxicology | 2023 | 37019170 | PubTator, text mining | PubMed |
| A structural vista of phosducin-like PhLP2A-chaperonin TRiC cooperation during the ATP-driven folding cycle. | bioRxiv | 2023 | 37016670 | PubTator, text mining | PubMed |
| Generation of peptides using phage display technology for cancer diagnosis and molecular imaging. | Mol Biol Rep | 2023 | 37014570 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6950/papers?page=7